<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Farhadi</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Bruninga</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Fields</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Keshavarzian</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group> (
  <year class="year">2001</year>). 
  <article-title class="article-title">Irritable bowel syndrome: an update on therapeutic modalities</article-title>. 
  <source class="source">Expert Opin. Investig. Drugs</source>
  <volume class="volume">10</volume>, 
  <fpage class="fpage">1211</fpage>â€“
  <lpage class="lpage">1222</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1517/13543784.10.7.1211</pub-id>
  <?supplied-pmid 11772245?>
  <pub-id pub-id-type="pmid" class="pub-id">11772245</pub-id>
 </mixed-citation>
</ref>
